PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
DOCS vs. APH
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between DOCS and APH is 0.34, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.0
Correlation: 0.3

Performance

DOCS vs. APH - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Doximity, Inc. (DOCS) and Amphenol Corporation (APH). The values are adjusted to include any dividend payments, if applicable.

0.00%50.00%100.00%NovemberDecember2025FebruaryMarchApril
-2.70%
95.53%
DOCS
APH

Key characteristics

Sharpe Ratio

DOCS:

1.23

APH:

0.35

Sortino Ratio

DOCS:

2.96

APH:

0.68

Omega Ratio

DOCS:

1.37

APH:

1.10

Calmar Ratio

DOCS:

1.23

APH:

0.51

Martin Ratio

DOCS:

7.79

APH:

1.39

Ulcer Index

DOCS:

12.21%

APH:

9.05%

Daily Std Dev

DOCS:

77.48%

APH:

36.21%

Max Drawdown

DOCS:

-80.53%

APH:

-63.42%

Current Drawdown

DOCS:

-49.45%

APH:

-18.15%

Fundamentals

Market Cap

DOCS:

$9.68B

APH:

$80.20B

EPS

DOCS:

$1.00

APH:

$1.86

PE Ratio

DOCS:

51.57

APH:

34.48

PEG Ratio

DOCS:

3.01

APH:

2.35

Total Revenue (TTM)

DOCS:

$432.11M

APH:

$11.97B

Gross Profit (TTM)

DOCS:

$390.70M

APH:

$4.05B

EBITDA (TTM)

DOCS:

$186.80M

APH:

$2.99B

Returns By Period

In the year-to-date period, DOCS achieves a -3.41% return, which is significantly higher than APH's -7.42% return.


DOCS

YTD

-3.41%

1M

-16.43%

6M

18.96%

1Y

99.50%

5Y*

N/A

10Y*

N/A

APH

YTD

-7.42%

1M

4.31%

6M

-0.19%

1Y

12.77%

5Y*

26.94%

10Y*

16.99%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

DOCS vs. APH — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

DOCS
The Risk-Adjusted Performance Rank of DOCS is 9393
Overall Rank
The Sharpe Ratio Rank of DOCS is 9292
Sharpe Ratio Rank
The Sortino Ratio Rank of DOCS is 9696
Sortino Ratio Rank
The Omega Ratio Rank of DOCS is 9494
Omega Ratio Rank
The Calmar Ratio Rank of DOCS is 9191
Calmar Ratio Rank
The Martin Ratio Rank of DOCS is 9494
Martin Ratio Rank

APH
The Risk-Adjusted Performance Rank of APH is 7272
Overall Rank
The Sharpe Ratio Rank of APH is 7373
Sharpe Ratio Rank
The Sortino Ratio Rank of APH is 6565
Sortino Ratio Rank
The Omega Ratio Rank of APH is 6767
Omega Ratio Rank
The Calmar Ratio Rank of APH is 8080
Calmar Ratio Rank
The Martin Ratio Rank of APH is 7474
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

DOCS vs. APH - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Doximity, Inc. (DOCS) and Amphenol Corporation (APH). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for DOCS, currently valued at 1.23, compared to the broader market-2.00-1.000.001.002.00
DOCS: 1.23
APH: 0.35
The chart of Sortino ratio for DOCS, currently valued at 2.96, compared to the broader market-4.00-2.000.002.004.00
DOCS: 2.96
APH: 0.68
The chart of Omega ratio for DOCS, currently valued at 1.37, compared to the broader market0.501.001.502.00
DOCS: 1.37
APH: 1.10
The chart of Calmar ratio for DOCS, currently valued at 1.23, compared to the broader market0.001.002.003.004.00
DOCS: 1.23
APH: 0.51
The chart of Martin ratio for DOCS, currently valued at 7.79, compared to the broader market-10.00-5.000.005.0010.0015.0020.00
DOCS: 7.79
APH: 1.39

The current DOCS Sharpe Ratio is 1.23, which is higher than the APH Sharpe Ratio of 0.35. The chart below compares the historical Sharpe Ratios of DOCS and APH, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio0.000.501.001.502.002.503.003.50NovemberDecember2025FebruaryMarchApril
1.23
0.35
DOCS
APH

Dividends

DOCS vs. APH - Dividend Comparison

DOCS has not paid dividends to shareholders, while APH's dividend yield for the trailing twelve months is around 0.94%.


TTM20242023202220212020201920182017201620152014
DOCS
Doximity, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
APH
Amphenol Corporation
0.94%0.79%0.86%1.06%0.73%0.80%0.89%1.09%0.80%0.86%1.01%0.84%

Drawdowns

DOCS vs. APH - Drawdown Comparison

The maximum DOCS drawdown since its inception was -80.53%, which is greater than APH's maximum drawdown of -63.42%. Use the drawdown chart below to compare losses from any high point for DOCS and APH. For additional features, visit the drawdowns tool.


-60.00%-50.00%-40.00%-30.00%-20.00%-10.00%0.00%NovemberDecember2025FebruaryMarchApril
-49.45%
-18.15%
DOCS
APH

Volatility

DOCS vs. APH - Volatility Comparison

Doximity, Inc. (DOCS) has a higher volatility of 19.77% compared to Amphenol Corporation (APH) at 17.63%. This indicates that DOCS's price experiences larger fluctuations and is considered to be riskier than APH based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


0.00%10.00%20.00%30.00%40.00%NovemberDecember2025FebruaryMarchApril
19.77%
17.63%
DOCS
APH

Financials

DOCS vs. APH - Financials Comparison

This section allows you to compare key financial metrics between Doximity, Inc. and Amphenol Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab